Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05379959 · ClinicalTrials.gov registry record · Early Phase 1
Effects of Stimulants on Behavioral and Neural Markers of Social Motivation, Ability, and Neural Markers of Social Function
A Early Phase 1 study, sponsored by University of Chicago.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 43
- Enrollment target
NCT05379959 is a Early Phase 1 study that has completed, run by University of Chicago. The registered enrollment target is 43 participants.
The verdict
NCT05379959, a Early Phase 1 study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 43 participants
- Enrollment target
Study Summary
To study the effects of MDMA, compared to a prototypical stimulant, on social motivation, social ability, and neural indices of social function in healthy volunteers
Interventions
- DRUG Methamphetamine
- DRUG MDMA
- DRUG placebo oral tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2022-05-11 |
| Est. Completion | 2023-10-24 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05379959
The ClinicalTrials.gov registry entry for NCT05379959 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Methamphetamine is the first listed.
NCT05379959 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05379959 about?
NCT05379959 is a clinical study titled "Effects of Stimulants on Behavioral and Neural Markers of Social Motivation, Ability, and Neural Markers of Social Function". To study the effects of MDMA, compared to a prototypical stimulant, on social motivation, social ability, and neural indices of social function in healthy volunteers
What is the current status of trial NCT05379959?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 43 participants. The study started on 2022-05-11. Estimated completion is 2023-10-24.
What interventions are being tested in trial NCT05379959?
The interventions under investigation include: Methamphetamine (DRUG), MDMA (DRUG), placebo oral tablet (DRUG).
Who is sponsoring clinical trial NCT05379959?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.